These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38918543

  • 1. Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis.
    Roh JH, Kim YG, Kim D, Park S, Park KS, Kim M, Hwang KW, Hwang W, Park GM, Lee JH.
    Sci Rep; 2024 Jun 25; 14(1):14679. PubMed ID: 38918543
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC, Lee HF, Chao TF, Li PR, Liu JR, Wu LS, Chang SH, Yeh YH, Kuo CT, Chan YH, Lip GYH.
    Cardiovasc Drugs Ther; 2021 Oct 25; 35(5):975-986. PubMed ID: 33211254
    [Abstract] [Full Text] [Related]

  • 3. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    Lee SR, Choi EK, Park CS, Han KD, Jung JH, Oh S, Lip GYH.
    J Am Coll Cardiol; 2019 Mar 05; 73(8):919-931. PubMed ID: 30819360
    [Abstract] [Full Text] [Related]

  • 4. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Harrington J, Carnicelli AP, Hua K, Wallentin L, Patel MR, Hohnloser SH, Giugliano RP, Fox KAA, Hijazi Z, Lopes RD, Pokorney SD, Hong H, Granger CB.
    Circulation; 2023 Jun 06; 147(23):1748-1757. PubMed ID: 37042255
    [Abstract] [Full Text] [Related]

  • 5. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL.
    J Cardiovasc Pharmacol Ther; 2019 Sep 06; 24(5):428-434. PubMed ID: 31035795
    [Abstract] [Full Text] [Related]

  • 6. Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry.
    Park H, Yu HT, Kim TH, Park J, Park JK, Kang KW, Shim J, Kim JB, Kim J, Choi EK, Park HW, Lee YS, Joung B.
    Yonsei Med J; 2023 Jan 06; 64(1):18-24. PubMed ID: 36579375
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD.
    Ann Intern Med; 2021 Jul 06; 174(7):910-919. PubMed ID: 33780291
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH, Lee HF, Chao TF, Wu CT, Chang SH, Yeh YH, See LC, Kuo CT, Chu PH, Wang CL, Lip GYH.
    Cardiovasc Drugs Ther; 2019 Dec 06; 33(6):701-710. PubMed ID: 31745687
    [Abstract] [Full Text] [Related]

  • 10. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J, Liu S, Segal JB, Alexander GC, McAdams-DeMarco M.
    BMC Nephrol; 2016 Oct 21; 17(1):157. PubMed ID: 27769175
    [Abstract] [Full Text] [Related]

  • 11. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
    Shiozawa M, Koga M, Inoue H, Yamashita T, Yasaka M, Suzuki S, Akao M, Atarashi H, Ikeda T, Okumura K, Koretsune Y, Shimizu W, Tsutsui H, Hirayama A, Nakahara J, Teramukai S, Kimura T, Morishima Y, Takita A, Yamaguchi T, Toyoda K.
    Int J Stroke; 2023 Oct 21; 18(8):986-995. PubMed ID: 37154598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.
    Li X, Pathadka S, Man KKC, Ng VWS, Siu CW, Wong ICK, Chan EW, Lau WCY.
    Drug Saf; 2020 Oct 21; 43(10):1023-1033. PubMed ID: 32557348
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation.
    Skjøth F, Larsen TB, Dun AR, Lilja M, Rahman I, Abdelgawwad K, Halvorsen S, Coleman C, Rivera M.
    Am J Med; 2024 Jun 21; 137(6):520-528.e13. PubMed ID: 38387539
    [Abstract] [Full Text] [Related]

  • 18. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chao TF, Lip GYH, Chen SA.
    JAMA Netw Open; 2020 Jun 01; 3(6):e206424. PubMed ID: 32478848
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.
    Tan J, Bae S, Segal JB, Zhu J, Alexander GC, Segev DL, McAdams-DeMarco M.
    Nephrology (Carlton); 2019 Feb 01; 24(2):234-244. PubMed ID: 29219209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.